Send to Friend
Cobra snapped up by Recipharm
Sotckholm's Recipharm has made a mandatory offer of 2.25p a share for Cobra Biomanufacturing, based in Keele and Oxford. Recipharm will loan monies to Cobra to meet its working capital requirements during the integration of the two businesses. Cobra CEO Simon Saxby said of the acquisition: "It's a welcome and essential step in order for Cobra to be able to provide long-term stability and increased scale needed for our clients."
Please complete the following fields to send the details of this item to your friend: